472 - Corticosteroid Exposure as a Risk Factor for Pneumocystis jirovecii Pneumonia Mortality in HIV-Negative Patients: A Multicenter Retrospective Case-Control Study with a Global Research Network Validation

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Lilian Vargas Barahona, University of Colorado

Transplant Infectious Diseases Fellow
MD
Denver, Colorado, United States

KM

Kyle C. Molina, PharmD, BCIDP, AAHIVP

Infectious Disease Clinical Pharmacy Specialist
University of Colorado Hospital
Aurora, Colorado, United States
LP

Laura C Pedraza-Arévalo, MD

St. Barnabas Hospital
New York City, New York, United States
SS

Stefan Sillau, PhD

Research Instructor, Biostatistician
University of Colorado
Denver, Colorado, United States
AT

Alex Tagawa, BS

Children's Hospital Colorado
Denver, Colorado, United States
SS

Sias Scherger, MD

University of Colorado
Denver, Colorado, United States
Daniel B. Chastain, Pharm.D., BCIDP, AAHIVP

Clinical Associate Professor
University of Georgia College of Pharmacy
Albany, Georgia, United States
LS

Leland Shapiro, MD

Associate Professor
Rocky Mountain Regional Veterans Affairs Medical Center
Denver, Colorado, United States
Carlos Franco-Paredes, MD, MPH

Adjunct Professor
Hospital Infantil de México, Federico Gómez
Denver, Colorado, United States
KH

Kellie Hawkins, MD, MPH

Denver Health Medical Center
Denver, Colorado, United States
AH

Andrés F. Henao-Martínez, MD

University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States